These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 10846625

  • 21. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
    Dai S, McNeill JH.
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
    [Abstract] [Full Text] [Related]

  • 22. Antihypertensive treatment in spontaneously hypertensive rats with streptozotocin-induced diabetes mellitus.
    Kusaka-Nakamura M, Kishi K, Miyazawa A, Yagi S, Sokabe H.
    Acta Physiol Hung; 1988 Dec; 71(2):251-69. PubMed ID: 3291554
    [Abstract] [Full Text] [Related]

  • 23. [The relations between doses of streptozotocin and pathosis in induced diabetes mellitus].
    Nishigaki A, Noma H, Kakizawa T.
    Shikwa Gakuho; 1989 Mar; 89(3):639-62. PubMed ID: 2533996
    [Abstract] [Full Text] [Related]

  • 24. Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin.
    Jian K, Fok E, Cam MC, Sambandam N, Yao J, Rodrigues B.
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1215-21. PubMed ID: 9028580
    [Abstract] [Full Text] [Related]

  • 25. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C, Schaan B, Oliveira E, Oliveira V, De Angelis K, Irigoyen M.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [Abstract] [Full Text] [Related]

  • 26. Reduction in hyperglycemia by mild food restriction in streptozotocin induced diabetic rats improves insulin sensitivity.
    Cameron-Smith D, Collier GR, O'Dea K.
    Horm Metab Res; 1994 Jul; 26(7):316-21. PubMed ID: 7959606
    [Abstract] [Full Text] [Related]

  • 27. Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
    Udayachalerm W, Vechakarn O, Patumraj S.
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S306-13. PubMed ID: 11529349
    [Abstract] [Full Text] [Related]

  • 28. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
    Bhadada SV, Goyal RK.
    Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
    [Abstract] [Full Text] [Related]

  • 29. Hyperinsulinemia and insulin resistance in hypertension: differential effects of antihypertensive agents.
    Goyal RK.
    Clin Exp Hypertens; 1999 Aug; 21(1-2):167-79. PubMed ID: 10052652
    [Abstract] [Full Text] [Related]

  • 30. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes.
    Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, Epstein PN, Ren J.
    J Mol Cell Cardiol; 2001 Sep; 33(9):1719-26. PubMed ID: 11549350
    [Abstract] [Full Text] [Related]

  • 31. Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension.
    Yousif MH, Akhtar S, Walther T, Benter IF.
    Cell Biochem Funct; 2008 Sep; 26(2):256-63. PubMed ID: 18035860
    [Abstract] [Full Text] [Related]

  • 32. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression.
    Sartoretto JL, Melo GA, Carvalho MH, Nigro D, Passaglia RT, Scavone C, Cuman RK, Fortes ZB.
    Life Sci; 2005 Oct 07; 77(21):2676-89. PubMed ID: 15964597
    [Abstract] [Full Text] [Related]

  • 33. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M, D'Aleo V, Lupi R, Paolini M, Soleti A, Marchetti P, Masiello P.
    Pancreas; 2007 Nov 07; 35(4):e10-7. PubMed ID: 18090226
    [Abstract] [Full Text] [Related]

  • 34. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
    Romanovsky D, Cruz NF, Dienel GA, Dobretsov M.
    Neurobiol Dis; 2006 Nov 07; 24(2):384-94. PubMed ID: 16935517
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
    George C, Lochner A, Huisamen B.
    J Ethnopharmacol; 2011 Sep 01; 137(1):298-304. PubMed ID: 21645608
    [Abstract] [Full Text] [Related]

  • 36. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
    Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S.
    J Endocrinol; 2006 Feb 01; 188(2):263-70. PubMed ID: 16461552
    [Abstract] [Full Text] [Related]

  • 37. Overweight and increased diabetes susceptibility in neonatally insulin-treated adult rats.
    Harder T, Rake A, Rohde W, Doerner G, Plagemann A.
    Endocr Regul; 1999 Mar 01; 33(1):25-31. PubMed ID: 10200585
    [Abstract] [Full Text] [Related]

  • 38. Streptozotocin-induced diabetic pregnant rats exhibit signs and symptoms mimicking preeclampsia.
    Ishihara G, Hiramatsu Y, Masuyama H, Kudo T.
    Metabolism; 2000 Jul 01; 49(7):853-7. PubMed ID: 10909994
    [Abstract] [Full Text] [Related]

  • 39. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
    Cam MC, Brownsey RW, Rodrigues B, McNeill JH.
    Metabolism; 2001 Jun 01; 50(6):674-80. PubMed ID: 11398144
    [Abstract] [Full Text] [Related]

  • 40. Quantitative morphometric study of the skeletal muscles of normal and streptozotocin-diabetic rats.
    Aughsteen AA, Khair AM, Suleiman AA.
    JOP; 2006 Jul 10; 7(4):382-9. PubMed ID: 16832135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.